APOTHEEK DEMARE
0841.635.148 · rovalta.com · 24/09/2026
APOTHEEK DEMARE
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOAPOTHEEK DEMARE is a Private limited company incorporated in 2011. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in De Panne. It employs on average 1,7 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0841.635.148
- Incorporation
- 08/12/2011
- Legal form
- Private limited company
- Registered office
- Zeelaan 75
8660 De Panne · FlandreSee on map - Contributed capital
- 6 200,00 €
- Latest accounts
- 31/12/2025
- Average workforce
- 1,7 ETP
Joint committees (1)
- 313
Financials
Source · NBB, 14 filingsTrend over 14 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 258,8 k € | +17.1% | 221 k € | -3.1% | 228 k € | +5.9% | 215,4 k € | -25.7% | 289,7 k € |
| EBITDA | 158 k € | +20.1% | 131,6 k € | -20.1% | 164,7 k € | +12.2% | 146,7 k € | -20.5% | 184,5 k € |
| Operating result | 125 k € | +25.9% | 99,3 k € | -24.2% | 130,9 k € | +17.5% | 111,4 k € | +8.1% | 103 k € |
| Net result | 77,1 k € | +24.6% | 61,9 k € | -24.7% | 82,1 k € | +34.9% | 60,9 k € | +10.0% | 55,4 k € |
| Balance sheet | |||||||||
| Equity | 361,8 k € | +16.7% | 310 k € | +19.9% | 258,6 k € | +31.0% | 197,4 k € | +18.6% | 166,5 k € |
| Total assets | 844,1 k € | +0.7% | 838,1 k € | -0.1% | 838,7 k € | -0.5% | 843,2 k € | -0.3% | 846 k € |
| Cash | 99,6 k € | -22.9% | 129,1 k € | +61.9% | 79,7 k € | -7.8% | 86,5 k € | +51.2% | 57,2 k € |
| Debts | 479,5 k € | -8.7% | 525,3 k € | -9.1% | 578 k € | -10.3% | 644,2 k € | -5.0% | 678,3 k € |
| Other | |||||||||
| Workforce | 1,7 ETP | -5.6% | 1,8 ETP | 0.0% | 1,8 ETP | -5.3% | 1,9 ETP | -13.6% | 2,2 ETP |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20252 active · 7 ended
Active mandates
Ended mandates
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 30/06/2026 | 03/07/2025 | 24/07/2024 | 17/07/2023 | 09/07/2022 | 21/06/2021 |
| General meeting | 27/06/2026 | 28/06/2025 | 22/06/2024 | 24/06/2023 | 17/06/2022 | 18/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 14 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 27/06/2026 | 30/06/2026 | Dutch | |
| Abridged model | 31/12/2024 | 28/06/2025 | 03/07/2025 | Dutch | |
| Abridged model | 31/12/2023 | 22/06/2024 | 24/07/2024 | Dutch | |
| Abridged model | 31/12/2022 | 24/06/2023 | 17/07/2023 | Dutch | |
| Abridged model | 31/12/2021 | 17/06/2022 | 09/07/2022 | Dutch | |
| Abridged model | 31/12/2020 | 18/06/2021 | 21/06/2021 | Dutch | |
| Abridged model | 31/12/2019 | 19/06/2020 | 22/06/2020 | Dutch | |
| Abridged model | 31/12/2018 | 21/06/2019 | 26/08/2019 | Dutch | |
| Abridged model | 31/12/2017 | 15/06/2018 | 09/08/2018 | Dutch | |
| Abridged model | 31/12/2016 | 16/06/2017 | 18/08/2017 | Dutch | |
| Abridged model | 31/12/2015 | 17/06/2016 | 09/08/2016 | Dutch | |
| Abridged model | 31/12/2014 | 19/06/2015 | 02/07/2015 | Dutch | |
| Abridged model | 31/12/2013 | 20/06/2014 | 07/08/2014 | Dutch | |
| Abridged model | 31/12/2012 | 21/06/2013 | 02/08/2013 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 500 k€ and 1 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20252 active · 7 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
Source · Belgian Official GazetteSimilar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 202577,1 k €↑
- 2024Annual accounts 202461,9 k €↓
- 2023Annual accounts 202382,1 k €↑
- 2022Annual accounts 202260,9 k €↑
- 2021Annual accounts 202155,4 k €↑
- 2021Name changeDEMARE Apotheek
- 2020Annual accounts 202027,1 k €↑
- 2019Annual accounts 201925,3 k €↑
- 2018Annual accounts 201810,5 k €↓
- 2017Annual accounts 201712 k €↓
- 2016Annual accounts 201630 k €↓
- 2015Annual accounts 201546,1 k €↑
- 2014Annual accounts 201445,5 k €↑
- 2013Annual accounts 20137,9 k €↑
- 2012Annual accounts 2012-266,9 €
- 2012Name changeAPOTHEEK DEMARE
- 08/12/2011IncorporationPrivate limited company